Emcure Pharma
Emcure Pharma gets Form 483 with two observations for API plant from USFDA
Emcure Pharma shares zoom over 35% in debut trade, closing at Rs 1,364.20
Emcure, Gennova settle litigation with HDT, ink pact to develop mRNA vaccines